Home
Fairmount Funds Management reported a 16.52% stake in Crescent Biopharma CBIO · 6,602,408 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 16.52%
- Last report
- 18.53% · filed 25/12/08
- Shares held
- 6,602,408 sh
- Class
- Ordinary Shares, $0.001 par value
- Event date
- 26/07/16
- Filed
- 26/07/20
16.52% stake · −2.0pp from the last report
- Stake
- 16.52%
- Last report
- 18.53%
- Since last report
- −2.0pp
Crescent Biopharma trades, last 26 weeks
What else happened in Crescent Biopharma around then
Filed or reported within 30 days of the trade day · 06/16~08/15Fairmount Funds Management's other 5% stake reports
- Fairmount Funds Management
5% stakeKorsana Biosciences
5% stakeKorsana Biosciences
KRSA
19.99% stake
9,106,420 sh
19.99% stake
Filed 09/11
- Fairmount Funds Management
5% stakeOruka Therapeutics
5% stakeOruka Therapeutics
ORKA
19.5% stake
14,572,917 sh
19.5% stake
Filed 07/01
- Fairmount Funds Management
5% stakeSpyre Therapeutics
5% stakeSpyre Therapeutics
SYRE
9.99% stake
9,667,201 sh
9.99% stake
Filed 06/23
- Fairmount Funds Management
5% stakeJade Biosciences
5% stakeJade Biosciences
JBIO
19.99% stake
14,069,494 sh
19.99% stake
Filed 06/09
- Fairmount Funds Management
5% stakeEnliven Therapeutics
5% stakeEnliven Therapeutics
ELVN
3.1% stake
1,855,644 sh
3.1% stake
Filed 05/15
